Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • eisai

Tag: eisai

You Searched For "eisai"
Eisai-Biogen Alzheimers drug Lecanemab should be priced below Aduhelm: Report

Eisai-Biogen Alzheimer's drug Lecanemab should be priced below Aduhelm: Report

Ruchika Sharma25 Dec 2022 8:30 AM GMT
Treatment with the drug may provide a small or even substantial benefit to patients with early Alzheimer's, but there remains a possibility of net...
Lupin rolls out Seizure drug Rufinamide in US

Lupin rolls out Seizure drug Rufinamide in US

Ruchika Sharma5 Dec 2022 9:45 AM GMT
Mumbai: Pharma major Lupin Limited today announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg in the United States market.The...
Roche to stop all Gantenerumab studies in early Alzheimers disease

Roche to stop all Gantenerumab studies in early Alzheimer's disease

Ruchika Sharma2 Dec 2022 9:00 AM GMT
Roche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...
Lupin bags USFDA okay for seizure treatment drug Rufinamide

Lupin bags USFDA okay for seizure treatment drug Rufinamide

Ruchika Sharma18 Aug 2022 9:53 AM GMT
Rufinamide Tablets will be manufactured at Lupin’s facility in Goa, India.
USFDA decision on Eisai, Biogen Alzheimers drug due in January

USFDA decision on Eisai, Biogen Alzheimer's drug due in January

Ruchika Sharma6 July 2022 4:30 AM GMT
Eisai in March downsized its role in Aduhelm, but remains the leader in the 50-50 partnership's lecanemab program.
Eisai gets Japanese orphan drug designation for ultrahigh-dose mecobalamin with prospective indication for functional impairment of amyotrophic lateral sclerosis

Eisai gets Japanese orphan drug designation for ultrahigh-dose mecobalamin with prospective indication for functional impairment of amyotrophic lateral sclerosis

Ruchika Sharma30 May 2022 5:30 AM GMT
ALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima

Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima

Ruchika Sharma30 Dec 2021 6:52 AM GMT
Kenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
Biogen gets USFDA Fast Track designation for lecanemab

Biogen gets USFDA Fast Track designation for lecanemab

Ruchika Sharma26 Dec 2021 4:00 AM GMT
Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the...
Dr Reddys, Citius Pharma ink pact to sell rights to anti-cancer agent

Dr Reddys, Citius Pharma ink pact to sell rights to anti-cancer agent

Ruchika Sharma4 Sep 2021 11:22 AM GMT
Hyderabad: Dr Reddy's Laboratories Ltd., announced that the company has entered into a definitive agreement with Citius Pharmaceuticals, Inc....
Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

Medical Dialogues Team19 Jun 2021 5:30 AM GMT
New Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop...
Biogen, Eisai secure USFDA accelerated nod for Alzheimer drug ADUHELM

Biogen, Eisai secure USFDA accelerated nod for Alzheimer drug ADUHELM

Ruchika Sharma8 Jun 2021 10:27 AM GMT
Cambridge: Biogen and Eisai, Co., Ltd. have announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok